Healthcare · Industry
Diagnostics & Research - List & Prices (45 stocks)
All 45 Diagnostics & Research stocks listed, ranked by market capitalization — 1 page(s), 50 per page.
What Are the Leading Diagnostics & Research Stocks?
Prices: Oct 21, 2026 close Last Updated: Oct 21, 2026There are 45 publicly traded Diagnostics & Research stocks. The largest by market capitalization are TMO, DHR, NTRA, A, IQV, WAT, IDXX, ILMN, MTD, DGX.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. | TMO | $694.02 | $256.61B | 37.4 | 0.27% |
| Danaher Corporation | DHR | $233.86 | $164.40B | 41.7 | 0.71% |
| Natera, Inc. | NTRA | $413.38 | $59.59B | — | |
| Agilent Technologies, Inc. | A | $177.75 | $50.12B | 35.1 | 0.59% |
| IQVIA Holdings Inc. | IQV | $276.63 | $45.53B | 34.4 | — |
| Waters Corporation | WAT | $457.47 | $44.92B | 115.8 | — |
| IDEXX Laboratories, Inc. | IDXX | $553.48 | $43.60B | 38.9 | — |
| Illumina, Inc. | ILMN | $282.86 | $42.71B | 52.8 | — |
| Mettler-Toledo International Inc. | MTD | $1,677.94 | $33.62B | 37.8 | — |
| Quest Diagnostics Incorporated | DGX | $238.93 | $26.37B | 25.4 | 1.45% |
| Labcorp Holdings Inc. | LH | $323.75 | $26.26B | 26.8 | 0.89% |
| Guardant Health, Inc. | GH | $166.66 | $22.37B | — | |
| Medpace Holdings, Inc. | MEDP | $662.48 | $18.49B | 38.9 | — |
| Revvity, Inc. | RVTY | $156.61 | $17.48B | 74.9 | 0.18% |
| Charles River Laboratories International, Inc. | CRL | $344.87 | $16.61B | — | |
| ICON Public Limited Company | ICLR | $185.25 | $14.29B | 195.0 | — |
| Qiagen N.V. | QGEN | $50.00 | $10.32B | 25.4 | 0.72% |
| GRAIL, Inc. | GRAL | $132.60 | $5.92B | — | |
| RadNet, Inc. | RDNT | $68.41 | $5.38B | — | |
| Sotera Health Company | SHC | $17.77 | $5.07B | 31.2 | — |
| BillionToOne, Inc. | BLLN | $104.67 | $4.62B | 148.3 | — |
| Adaptive Biotechnologies Corporation | ADPT | $25.33 | $4.04B | — | |
| Veracyte, Inc. | VCYT | $46.22 | $3.72B | 33.0 | — |
| CareDx, Inc. | CDNA | $70.74 | $3.38B | 31.5 | — |
| NeoGenomics, Inc. | NEO | $17.04 | $2.19B | — | |
| GeneDx Holdings Corp. | WGS | $68.94 | $2.06B | — | |
| Personalis, Inc. | PSNL | $15.90 | $1.70B | — | |
| Freenome, Inc. | FRNM | $14.01 | $1.51B | — | |
| OPKO Health, Inc. | OPK | $1.60 | $1.19B | — | |
| Castle Biosciences, Inc. | CSTL | $34.37 | $1.05B | — | |
| Fulgent Genetics, Inc. | FLGT | $20.13 | $553.88M | — | |
| Myriad Genetics, Inc. | MYGN | $5.57 | $532.77M | — | |
| Spectral Medical Inc. | EDT.TO | CA$1.09 | CA$319.97M | — | |
| Biodesix, Inc. | BDSX | $23.93 | $251.86M | — | |
| Exagen Inc. | XGN | $7.88 | $190.90M | — | |
| Burning Rock Biotech Limited | BNR | $13.51 | $142.48M | — | |
| Insight Molecular Diagnostics Inc. | IMDX | $3.02 | $98.83M | — | |
| Quantum Cyber N.V. | QUCY | $1.02 | $88.96M | — | |
| Precipio, Inc. Common Stock | PRPO | $21.25 | $38.04M | — | |
| MDxHealth SA | MDXH | $0.21 | $20.50M | — | |
| ENDRA Life Sciences Inc. Common Stock | NDRA | $4.68 | $7.02M | — | |
| XWELL, Inc. | XWEL | $0.70 | $6.99M | — | |
| Advanced Biomed Inc. | ADVB | $3.76 | $6.21M | — | |
| bioAffinity Technologies, Inc. | BIAF | $3.57 | $4.50M | — | |
| iSpecimen Inc. | ISPC | $0.89 | $2.25M | — |
Thermo Fisher Scientific Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $256.61B
- P/E
- 37.4
- Dividend Yield
- 0.27%
Danaher Corporation
Healthcare / Diagnostics & Research
- Market Cap
- $164.40B
- P/E
- 41.7
- Dividend Yield
- 0.71%
Natera, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $59.59B
- P/E
- unprofitable
Agilent Technologies, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $50.12B
- P/E
- 35.1
- Dividend Yield
- 0.59%
IQVIA Holdings Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $45.53B
- P/E
- 34.4
Waters Corporation
Healthcare / Diagnostics & Research
- Market Cap
- $44.92B
- P/E
- 115.8
IDEXX Laboratories, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $43.60B
- P/E
- 38.9
Illumina, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $42.71B
- P/E
- 52.8
Mettler-Toledo International Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $33.62B
- P/E
- 37.8
Quest Diagnostics Incorporated
Healthcare / Diagnostics & Research
- Market Cap
- $26.37B
- P/E
- 25.4
- Dividend Yield
- 1.45%
Labcorp Holdings Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $26.26B
- P/E
- 26.8
- Dividend Yield
- 0.89%
Guardant Health, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $22.37B
- P/E
- unprofitable
Medpace Holdings, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $18.49B
- P/E
- 38.9
Revvity, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $17.48B
- P/E
- 74.9
- Dividend Yield
- 0.18%
Charles River Laboratories International, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $16.61B
- P/E
- unprofitable
ICON Public Limited Company
Healthcare / Diagnostics & Research
- Market Cap
- $14.29B
- P/E
- 195.0
Qiagen N.V.
Healthcare / Diagnostics & Research
- Market Cap
- $10.32B
- P/E
- 25.4
- Dividend Yield
- 0.72%
GRAIL, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $5.92B
- P/E
- unprofitable
RadNet, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $5.38B
- P/E
- unprofitable
Sotera Health Company
Healthcare / Diagnostics & Research
- Market Cap
- $5.07B
- P/E
- 31.2
BillionToOne, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $4.62B
- P/E
- 148.3
Adaptive Biotechnologies Corporation
Healthcare / Diagnostics & Research
- Market Cap
- $4.04B
- P/E
- unprofitable
Veracyte, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $3.72B
- P/E
- 33.0
CareDx, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $3.38B
- P/E
- 31.5
NeoGenomics, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $2.19B
- P/E
- unprofitable
GeneDx Holdings Corp.
Healthcare / Diagnostics & Research
- Market Cap
- $2.06B
- P/E
- unprofitable
Personalis, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.70B
- P/E
- unprofitable
Freenome, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.51B
- P/E
- unprofitable
OPKO Health, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.19B
- P/E
- unprofitable
Castle Biosciences, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.05B
- P/E
- unprofitable
Fulgent Genetics, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $553.88M
- P/E
- unprofitable
Myriad Genetics, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $532.77M
- P/E
- unprofitable
Spectral Medical Inc.
Healthcare / Diagnostics & Research
- Market Cap
- CA$319.97M
- P/E
- unprofitable
Biodesix, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $251.86M
- P/E
- unprofitable
Exagen Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $190.90M
- P/E
- unprofitable
Burning Rock Biotech Limited
Healthcare / Diagnostics & Research
- Market Cap
- $142.48M
- P/E
- unprofitable
Insight Molecular Diagnostics Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $98.83M
- P/E
- unprofitable
Quantum Cyber N.V.
Healthcare / Diagnostics & Research
- Market Cap
- $88.96M
- P/E
- unprofitable
Precipio, Inc. Common Stock
Healthcare / Diagnostics & Research
- Market Cap
- $38.04M
- P/E
- unprofitable
MDxHealth SA
Healthcare / Diagnostics & Research
- Market Cap
- $20.50M
- P/E
- unprofitable
ENDRA Life Sciences Inc. Common Stock
Healthcare / Diagnostics & Research
- Market Cap
- $7.02M
- P/E
- unprofitable
XWELL, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $6.99M
- P/E
- unprofitable
Advanced Biomed Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $6.21M
- P/E
- unprofitable
bioAffinity Technologies, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $4.50M
- P/E
- unprofitable
iSpecimen Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $2.25M
- P/E
- unprofitable
Showing 1–45 of 45 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data. Ranked by market capitalization. Prices are the most recent daily close.
Which Diagnostics & Research Stocks Are Reasonably Valued?
Prices: Oct 21, 2026 closeAmong the 45 largest Diagnostics & Research companies, Quest Diagnostics Incorporated (DGX) trades at the lowest trailing P/E ratio, 25.4. The industry average is 56.9.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated | DGX | $238.93 | $26.37B | 25.4 | 1.45% |
| Qiagen N.V. | QGEN | $50.00 | $10.32B | 25.4 | 0.72% |
| Labcorp Holdings Inc. | LH | $323.75 | $26.26B | 26.8 | 0.89% |
| Sotera Health Company | SHC | $17.77 | $5.07B | 31.2 | — |
| CareDx, Inc. | CDNA | $70.74 | $3.38B | 31.5 | — |
Ranked by trailing twelve-month P/E, lowest first. Companies that report no P/E are not listed. Rankings cover the 45 largest Diagnostics & Research companies by market capitalization.
Which Diagnostics & Research Stocks Pay the Highest Dividends?
Prices: Oct 21, 2026 close7 of the 45 largest Diagnostics & Research companies pay a dividend. Quest Diagnostics Incorporated (DGX) has the highest yield at 1.45%.
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated | DGX | $238.93 | $26.37B | 25.4 | 1.45% |
| Labcorp Holdings Inc. | LH | $323.75 | $26.26B | 26.8 | 0.89% |
| Qiagen N.V. | QGEN | $50.00 | $10.32B | 25.4 | 0.72% |
| Danaher Corporation | DHR | $233.86 | $164.40B | 41.7 | 0.71% |
| Agilent Technologies, Inc. | A | $177.75 | $50.12B | 35.1 | 0.59% |
Ranked by trailing dividend yield, highest first. Companies that pay no dividend are not listed. Rankings cover the 45 largest Diagnostics & Research companies by market capitalization.
Key facts
As of October 21, 2026, 45 Diagnostics & Research stocks are listed: 44 on NYSE & NASDAQ and 1 on TSX (Toronto Stock Exchange). A company listed on more than one exchange is counted once.
The largest by market capitalization is Thermo Fisher Scientific Inc. (TMO) at $256.61B.
The median P/E across the Diagnostics & Research industry is 37.6.
Diagnostics & Research Industry Overview
From the data · Oct 21, 2026The Diagnostics & Research industry, part of the Healthcare sector, includes 45 publicly traded companies with a combined market capitalization of $937.07B in US dollars. A further CA$319.97M is quoted in CAD, across 1 listed company. The industry is led by Thermo Fisher Scientific Inc. (TMO), Danaher Corporation (DHR), Natera, Inc. (NTRA).
Among the 45 listed Diagnostics & Research companies, market capitalizations range from $256.61B (Thermo Fisher Scientific Inc.) down to $2.25M (iSpecimen Inc.), highlighting the wide size disparity across the industry.
Diagnostics & Research Industry Valuation
The Diagnostics & Research industry currently trades at an average price-to-earnings (P/E) ratio of 56.9. This elevated multiple indicates that investors are pricing in strong future earnings growth across Diagnostics & Research companies. Note that some companies in the industry report no P/E ratio, typically because they are currently unprofitable or in early growth stages.
Diagnostics & Research Dividend Profile
7 out of 45 Diagnostics & Research companies (16%) currently pay dividends to shareholders. The average dividend yield across dividend-paying Diagnostics & Research stocks is 0.69%. Most Diagnostics & Research companies reinvest earnings into growth rather than paying dividends, which is typical for earlier-stage or high-growth industries.
Frequently Asked Questions
What are the leading Diagnostics & Research stocks?
The largest Diagnostics & Research stocks by market capitalization are Thermo Fisher Scientific Inc. (TMO), Danaher Corporation (DHR), Natera, Inc. (NTRA), Agilent Technologies, Inc. (A), IQVIA Holdings Inc. (IQV). All 45 companies are ranked by market cap on this page.
Where can I find a complete list of Diagnostics & Research stocks?
This page is the complete list: 45 Diagnostics & Research companies across 1 page(s), 50 per page, ranked by market capitalization — including TMO, DHR, NTRA, A, IQV.
How many Diagnostics & Research stocks are there?
There are 45 publicly traded Diagnostics & Research companies: 44 on NYSE & NASDAQ and 1 on TSX (Toronto Stock Exchange). By market capitalization, they range from Thermo Fisher Scientific Inc. (TMO) to iSpecimen Inc. (ISPC). A company listed on more than one exchange is counted once. This directory spans 1 pages, with all companies sorted by market cap for easy comparison.
Which Diagnostics & Research stocks are reasonably valued?
Among the 45 largest Diagnostics & Research companies, Quest Diagnostics Incorporated (DGX) carries the lowest trailing P/E at 25.4, against an industry average of 56.9.
Which Diagnostics & Research stocks have the highest dividend yield?
7 of the 45 Diagnostics & Research companies (16%) pay a dividend, with an average yield of 0.69% among payers. The highest yield among the 45 largest is Quest Diagnostics Incorporated (DGX) at 1.45%.
Explore Diagnostics & Research Stocks on StockVS
StockVS provides detailed fundamental data, historical price charts, and side-by-side comparisons for all 45 Diagnostics & Research companies. Browse individual stock pages for in-depth analysis, or use our comparison tool to evaluate two Diagnostics & Research stocks head to head. All data is updated regularly to reflect the latest available financials.